|
1
|
Zagouri F, Sergentanis TN, Tsigginou A,
Dimitrakakis C, Zografos GC, Dimopoulos MA and Psaltopoulou T:
Female breast cancer in Europe: Statistics, diagnosis and treatment
modalities. J Thorac Dis. 6:589–590. 2014.PubMed/NCBI
|
|
2
|
Woolston C: Breast cancer. Nature.
527:S1012015. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
DeSantis CE, Ma J, Gaudet MM, Newman LA,
Miller KD, Sauer AG, Jemal A and Siegel RL: Breast cancer
statistics, 2019. CA Cancer J Clin. 69:438–451. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ai H, Zhou W, Wang Z, Qiong G, Chen Z and
Deng S: MicroRNAs-107 inhibited autophagy, proliferation, and
migration of breast cancer cells by targeting HMGB1. J Cell
Biochem. 2:10022018.
|
|
5
|
Cedolini C, Bertozzi S, Londero AP,
Bernardi S, Seriau L, Concina S, Cattin F and Risaliti A: Type of
breast cancer diagnosis, screening, and survival. Clin Breast
Cancer. 14:235–240. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Metzger-Filho O, Tutt A, de Azambuja E,
Saini KS, Viale G, Loi S, Bradbury I, Bliss JM, Azim HA Jr, Ellis
P, et al: Dissecting the heterogeneity of triple-negative breast
cancer. J Clin Oncol. 30:1879–1887. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Karaayvaz M, Cristea S, Gillespie SM,
Patel AP, Mylvaganam R, Luo CC, Specht MC, Bernstein BE, Michor F
and Ellisen LW: Unravelling subclonal heterogeneity and aggressive
disease states in TNBC through single-cell RNA-seq. Nat Commun.
9:35882018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Denkert C, Liedtke C, Tutt A and von
Minckwitz G: Molecular alterations in triple-negative breast
cancer-the road to new treatment strategies. Lancet. 389:2430–2442.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Costa FF: Non-coding RNAs: New players in
eukaryotic biology. Gene. 357:83–94. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mou E and Wang H: LncRNA LUCAT1
facilitates tumorigenesis and metastasis of triple-negative breast
cancer through modulating miR-5702. Biosci Rep. 39:BSR201904892019.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ai B, Kong X, Wang X, Zhang K, Yang X,
Zhai J, Gao R, Qi Y, Wang J, Wang Z and Fang Y: LINC01355
suppresses breast cancer growth through FOXO3-mediated
transcriptional repression of CCND1. Cell Death Dis. 10:5022019.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lin CY, Zhang SN, Wang Y, Wang Y, Nice E,
Guo C, Zhang E, Yu L, Li M, Liu C, et al: Functional role of a
novel long noncoding RNA TTN-AS1 in esophageal squamous cell
carcinoma progression and metastasis. Clin Cancer Res. 24:486–498.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen P, Wang R, Yue QF and Hao MM: Long
non-coding RNA TTN-AS1 promotes cell growth and metastasis in
cervical cancer via miR-573/E2F3. Biochem Biophys Res Commun.
503:2956–2962. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cui ZH, Luo ZY, Lin ZM, Shi LH, Hong YR
and Yan C: Long non-coding RNA TTN-AS1 facilitates tumorigenesis of
papillary thyroid cancer through modulating the miR-153-3p/ZNRF2
axis. J Gene Med. 21:102019. View
Article : Google Scholar
|
|
15
|
Zhang SY, Ma HY, Zhang DM, Xie S, Wang W,
Li Q, Lin Z and Wang Y: LncRNA KCNQ1OT1 regulates proliferation and
cisplatin resistance in tongue cancer via miR-211-5p mediated
Ezrin/Fak/Src signaling. Cell Death Dis. 9:162018.PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang JG, Wang L, Xu XL, et al:
Transcriptome-Based Network Analysis Unveils Eight Immune-Related
Genes as Molecular Signatures in the Immunomodulatory Subtype of
Triple-Negative Breast Cancer. Front. Oncol. 10–19. 2020.PubMed/NCBI
|
|
18
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
StarBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42:D92–D97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou XP, Wang YP, Li Q, Ma DH, Nie AQ and
Shen XL: LncRNA linc-PINT inhibits miR-523-3p to hamper
retinoblastoma progression by upregulating dickkopf-1 (DKK1).
Biochem Biophys Res Commun. 530:47–53. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qu XH, Shi YL, Ma Y, Bao WW, Yang L, Li JC
and Zhang F: LncRNA DANCR regulates the growth and metastasis of
oral squamous cell carcinoma cells via altering miR-216a-5p
expression. Hum Cell. 33:1281–1293. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xia Y, Zhou Y, Han H, Li P, Wei W and Lin
NX: lncRNA NEAT1 facilitates melanoma cell proliferation,
migration, and invasion via regulating miR-495-3p and E2F3. J Cell
Physiol. 234:19592–19601. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li CL, Lv YL, Shao CY, Chen C, Zhang T,
Wei Y, Fan H, Lv T, Liu H and Song Y: Tumor-derived exosomal lncRNA
GAS5 as a biomarker for early-stage non-small-cell lung cancer
diagnosis. J Cell Physiol. 234:20721–20727. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Luo LY, Tang HL, Ling L, Li N, Jia X,
Zhang Z, Wang X, Shi L, Yin J, Qiu N, et al: LINC01638 lncRNA
activates MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc
degradation in triple-negative breast cancer. Oncogene.
37:6166–6179. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang G, Li H, Sun R, Li P, Yang Z, Liu Y,
Wang Z, Yang Y and Yin C: Long non-coding RNA ZEB2-AS1 promotes the
proliferation, metastasis and epithelial mesenchymal transition in
triple-negative breast cancer by epigenetically activating ZEB2. J
Cell Mol Med. 23:3271–3279. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Quan J, Pan X, He T, Lin C and Lai Y, Chen
P, Zhang Z, Yang S, Wang T and Lai Y: Tumor suppressor miR-211-5p
is associated with cellular migration, proliferation and apoptosis
in renal cell carcinoma. Exp Ther Med. 15:4019–4028.
2018.PubMed/NCBI
|
|
26
|
Liang MH, Jia JL, Chen LL, Wei B, Guan Q,
Ding Z, Yu J, Pang R and He G: LncRNA MCM3AP-AS1 promotes
proliferation and invasion through regulating miR-211-5p/SPARC axis
in papillary thyroid cancer. Endocrine. 65:318–326. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen LL, Zhang ZJ, Yi ZB and Li JJ:
MicroRNA-211-5p suppresses tumour cell proliferation, invasion,
migration and metastasis in triple-negative breast cancer by
directly targeting SETBP1. Br J Cancer. 117:78–88. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang W, Cui G, Ding M, Yang M and Dai D:
MicroRNA-124-3p.1 promotes cell proliferation through
axin1-dependent wnt signaling pathway and predicts a poor prognosis
of triple-negative breast cancer. J Clin Lab Anal.
3:e232662020.
|
|
29
|
Schroeder A, Heller DA, Winslow MM,
Dahlman JE, Pratt GW, Langer R, Jacks T and Anderson DG: Treating
metastatic cancer with nanotechnology. Nat Rev Cancer. 12:39–50.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang B, Shetti D, Fan C and Wei K:
MiR-29b-3p promotes progression of MDA-MB-231 triple-negative
breast cancer cells through downregulating TRAF3. Biol Res.
52:382019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chang Q, Bournazou E, Sansone P, Berishaj
M, Gao SP, Daly L, Wels J, Theilen T, Granitto S, Zhang X, et al:
The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and
metastasis. Neoplasia. 15:848–862. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kamran MZ, Patil P and Gude RP: Role of
STAT3 in cancer metastasis and translational advances. Biomed Res
Int. 2013:4218212013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xie Q, Yang Z, Huang X, Zhang Z, Li J, Ju
J, Zhang H and Ma J: Ilamycin C induces apoptosis and inhibits
migration and invasion in triple-negative breast cancer by
suppressing IL-6/STAT3 pathway. J Hematol Oncol. 12:602019.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ning N, Liu SL, Liu XH, Tian Z, Jiang Y,
Yu N, Tan B, Feng H, Feng X and Zou L: Curcumol inhibits the
proliferation and metastasis of melanoma via the
miR-152-3p/PI3K/AKT and ERK/NF-kB signaling pathways. J Cancer.
11:1679–1692. 2020. View Article : Google Scholar : PubMed/NCBI
|
